JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peng, S.
Right arrow Articles by Atchison, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peng, S.
Right arrow Articles by Atchison, W. D.

Vol. 302, Issue 2, 424-432, August 2002


Effects of Methylmercury on Human Neuronal L-Type Calcium Channels Transiently Expressed in Human Embryonic Kidney Cells (HEK-293)

Shuangqing Peng, Ravindra K. Hajela and William D. Atchison

Department of Pharmacology and Toxicology, Institute of Environmental Toxicology, and Neuroscience Program, Michigan State University, East Lansing, Michigan

    Abstract
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Methylmercury (MeHg) disrupts the function of native, high voltage-activated neuronal Ca2+ channels in several types of cells. However, the effects of MeHg on isolated Ca2+ channel phenotypes have not been examined. The aim of the present study was to examine the action of MeHg on recombinant, neuronal L-type voltage-sensitive Ca2+ channels. Human embryonic kidney cells (HEK-293) were transfected with human neuronal cDNA clones of the alpha 1C-1 subunit in combination with alpha 2b and beta 3a Ca2+ channel subunits and the reporter jellyfish green fluorescent protein for transient expression. Current from expressed channels (IBa) and their response to MeHg applied acutely were measured using whole-cell voltage-clamp recording techniques and Ba2+ (5 mM) as charge carrier. Amplitude of IBa in these cells was reduced by the dihydropyridine (DHP), nimodipine, and enhanced by Bay K8644 [S-(-)-1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-[trifluoromethyl]phenyl)-3 pyridine carboxylic acid methyl ester]. MeHg (0.125-5.0 µM) caused a time- and concentration-dependent reduction in amplitude of the peak and sustained current through these channels. However, even at the highest concentration of MeHg tested, reduction of current amplitude by MeHg was incomplete. Washing with MeHg-free solution could not reverse its effects. The steady-state inactivation curve was unaltered by MeHg. Increasing the stimulation frequency or the extracellular Ba2+ concentration each attenuated slightly the reduction in amplitude of IBa by MeHg. In the presence of MeHg (5.0 µM), Bay K8644 still increased the remaining current, and nimodipine (10 µM) reduced residual current that was resistant to MeHg. Thus, although MeHg reduces the amplitude of recombinant, heterologously expressed L-type channel current, a portion of current is resistant to reduction by MeHg. Furthermore, DHP agonists and antagonists retain their ability to affect L-type Ca2+ channel current even in the presence of MeHg.

    Introduction
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Voltage-sensitive Ca2+ channels play critical roles in a number of cellular functions such as synaptic transmission, muscle contraction, and regulation of gene expression (Catterall, 1998). Several distinct subtypes of "high voltage-activated" Ca2+ channels (L, N, P/Q, and R) have been identified based on their biophysical and pharmacological properties (Tsien et al., 1995). L-type channels, the subject of the present study, are present in various forms in both neurons and other kinds of cells. Ca2+ channels in general are affected by the actions of a number of toxicants (Kiss and Osipenko, 1994; Sirois and Atchison, 1996). Because of the crucial roles these proteins play in key cellular functions, toxicant effects on Ca2+ channels could have significant deleterious consequences on cell function (Audesirk et al., 2001).

Methylmercury (MeHg) is an important environmental contaminant that has been responsible for episodes of mass environmental neurotoxicity in Minamata, Japan (Takeuchi, 1982) and Iraq (Bakir et al., 1973). MeHg neurotoxicity remains a contemporary concern, especially for populations with a high component of fish in their diet (Kosatsky and Dumont 1991; Grandjean et al., 1997; Hansen and Danscher, 1997; Renzoni et al., 1998). The mechanisms underlying MeHg neurotoxicity are unclear, and multiple sites of action probably contribute to the ultimate expression of toxicity (Atchison and Hare, 1994). Among the many cellular targets associated with effects of MeHg, voltage-gated Ca2+ channels including, apparently, the L-type, are affected rapidly and at low micromolar concentrations in isolated systems.

The actions of MeHg on Ca2+ channels are conflicting, depending upon the type of measurement being made. Like divalent heavy metals such as Pb2+, Cd2+, and inorganic Hg2+, acute application of MeHg to cells in culture causes a marked reduction in amplitude of native currents carried through Ca2+ channels (Shafer and Atchison, 1991; Sirois and Atchison, 2000). Similarly, reduced influx of 45Ca2+ during KCl-induced depolarization results from extremely brief (1 s) exposures to MeHg in rat cortical synaptosomes (Atchison et al., 1986; Shafer and Atchison, 1989; Shafer et al., 1990; Hewett and Atchison, 1992). However, in functional assays of effects of MeHg on regulation of intracellular free Ca2+ using measurements of Fura-2 acetoxymethyl ester fluorescence, continuous exposure to MeHg (0.1-5 µM) for periods of up to an hour induces an increase in intracellular Ca2+, part of which occurs by entry of Ca2+ from the extracellular medium (Denny et al., 1993; Hare et al., 1993). In both NG108-15 cells and primary cultures of cerebellar granule cells, nifedipine, a dihydropyridine (DHP)-type blocker of L-type Ca2+ channels, delays the onset of this MeHg-mediated influx of extracellular Ca2+ (Hare and Atchison 1995; Marty and Atchison 1997), and partially protects granule cells in culture from MeHg-induced cytotoxicity (Marty and Atchison, 1998). Moreover, in vivo administration of nifedipine and other Ca2+ channel blockers protects rats from MeHg-induced neurotoxicity (Sakamoto et al., 1996). These observations suggest that at least some of the effects of MeHg are mediated by L-type Ca2+ channels or, alternatively, that MeHg, like Pb2+ (Simons and Pocock, 1987), may enter neurons by means of L-type Ca2+ channels.

To begin to reconcile these seemingly contradictory effects of MeHg and hence understand more clearly the actions of MeHg on voltage-gated Ca2+ channels, we undertook the first study of actions of MeHg on a homogeneous population of a single defined phenotype of Ca2+ channels. One problem with existing studies using native cell currents is that multiple types of Ca2+ channels occur in these preparations (Sirois and Atchison, 2000), and pharmacological methods for isolating a single phenotype are incomplete. Thus, theoretically, MeHg could act differentially on different subtypes of Ca2+ channels, perhaps impeding current flow through one subtype, while not affecting, or actually facilitating, current flow through another. Because of the protective effects of L-type Ca2+ channel antagonists against MeHg-induced neurotoxicity in several experimental paradigms, we chose to focus initially on this phenotype in isolation using a heterologous expression system. Specifically, the goal of the present study was to determine whether current through L-type voltage-sensitive Ca2+ channels was reduced by acute administration of MeHg and, if so, what were the characteristics of reduction of channel function by MeHg.

To do this, we used recombinant clones of human neuronal L-type Ca2+ channels expressed using cDNA copies of their genes transferred into human embryonic kidney cells (HEK-293). These nonexcitable cells are commonly used for heterologous expression of membrane proteins including voltage-dependent Ca2+ channels (Williams et al., 1994; Perez-Garcia et al., 1995; Querfurth et al., 1998). Whole-cell voltage-clamp methods were used to characterize the currents expressed in these cells, and then to examine the actions of MeHg on these currents.

    Experimental Procedures
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Materials. Human embryonic kidney cells (HEK-293, ATCC number CRL-1573) were purchased from the American Type Culture Collection (Manassas, VA). All reagents were pure or ultra-pure laboratory grade unless otherwise noted. S-(-)-Bay K8644, (-)-nimodipine, ATP-Mg, cAMP, HEPES, EGTA, and tetrodotoxin were obtained from Sigma-Aldrich (St. Louis, MO). Bay K8644 and nimodipine were made up as stock solutions in absolute ethanol to give final concentrations in solutions, which limited the ethanol concentration to less than 0.1% (v/v). Stock solutions (5 mM) of methylmercuric chloride (MeHg) (ICN Pharmaceuticals, Costa Mesa, CA) were prepared weekly in double distilled water, from which test solutions were prepared daily in extracellular solution. Expression cDNA clone plasmids of the human neuronal Ca2+ channel subunits used in the study were all generously provided by Dr. Kenneth A. Stauderman of SIBIA Neurosciences (San Diego, CA), now Merck Research Laboratories. alpha 1C-1 and beta 3a cDNA were isolated from hippocampus (Mark Williams, Merck Research, personal communication); alpha 2b was isolated from cerebellum (Williams et al., 1992).

Cell Culture and Transfection. HEK-293 cells were grown at 37°C in Eagle's minimal essential medium fortified with 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 2 mM L-glutamine, 1.5 g/l sodium bicarbonate, 10% fetal bovine serum, and penicillin/streptomycin/amphotericin B (Invitrogen, Carlsbad, CA) in a 5% CO2 environment. One day before gene transfer, cells were plated at a density of 5 × 105 on 35-mm culture dishes. Cells were transfected with a mixture of plasmids containing alpha 1C-1, alpha 2b, and beta 3a Ca2+ channel subunits and a jellyfish green fluorescent protein (GFP) cDNA sequence using Fugene 6 (Roche Applied Science, Indianapolis, IN) following the manufacturer's instructions. Reactions contained a total of 3 µl of Fugene 6 and 1 µg of plasmid DNA containing the three subunits in a 1:1:1 molar ratio, with GFP plasmid at 20% of the total DNA. Two days were allowed for optimal transient expression of proteins, at which time the cells were examined for GFP expression. Cells from dishes with a reasonable number of green fluorescent cells (usually 20%) were replated at a lower density to facilitate recording. Recordings were typically made using cells from a minimum of three independent transfections.

Ca2+ Channel Current Recording. Prior to recording, culture medium was removed, and cells were rinsed twice with extracellular solution and then replenished with 1 ml of extracellular recording bath solution. The extracellular solution contained 150 mM tetraethylammonium chloride, 5 mM BaCl2, 1 mM MgCl2, 25 mM D-glucose, 10 mM HEPES, 0.001 mM tetrodotoxin, pH adjusted to 7.2 at room temperature (~23-25°C) with tetraethylammonium hydroxide. The osmolarity of solution was 310 mOsm. In some experiments, [BaCl2] was increased to 20 mM; the tetraethylammonium chloride concentration was simultaneously reduced to 117 mM to maintain iso-osmolarity. Patch-clamp pipettes with resistances between 6 and 8 MOmega were prepared from 1.5-mm-i.d. glass capillaries (World Precision Instruments, Sarasota, FL) using a PP-830 two-stage microelectrode puller (Narishige, Tokyo, Japan) and fire-polished using an MF-830 microforge (Narishige). The intracellular (pipette) solution contained 140 mM CsCl, 10 mM EGTA, 10 mM HEPES, 2 mM ATP-Mg, and 1 mM cAMP; pH was adjusted to 7.2 at room temperature with CsOH.

The tight-seal, whole-cell configuration of the patch-clamp technique (Hamill et al., 1981) was used on fluorescent green cells to record Ba2+ currents (IBa) through transiently expressed Ca2+ channels and study the effects of MeHg or other pharmacological agents on them. Whole-cell currents were recorded using an Axopatch-1D amplifier (Axon Instruments, Union City, CA), sampled at 10 kHz, filtered at 2 kHz (-3 dB, four-pole Bessel filter; Axon Instruments) and acquired online using the pClamp6 program (Axon Instruments). Pipette and cell capacitance were compensated online in all experiments. Series resistance was also compensated online in the range of 60 to 80%. Extracellular media were exchanged using a gravity-fed bath perfusion system (BPS-4; ALA Scientific Instruments, Westbury, NY); the flow rate was 5 × 10-3 ml/s. The distance of the flow pipette from the cell remained approximately 150 µm and the pipette tip diameter was 300 µm. All experiments were carried out at room temperature (~23-25°C).

Except when noted otherwise, a pulse protocol was used to examine the effects of MeHg on membrane currents. A hyperpolarizing pulse with one-quarter of the test pulse magnitude was applied to measure the leak current, followed by a depolarizing pulse to elicit inward current. Linear components of leak and capacitive current were not subtracted online from these records. Thus, effects of MeHg on inward current, leak current, and capacitive current could be examined in consecutive current traces. This pulse protocol was repeated once every 10 s. Leak subtraction was performed offline, subtracting the scaled current observed with the P/N protocol. For some experiments, a ramp protocol was used. The duration of the ramp was 150 ms and the interval between ramps was 30 s.

Statistical Analysis. Origin (MicroCal, Northampton, MA) and pClamp (Axon Instruments) software suites were used to perform linear and nonlinear fit of data. Statistical comparisons were performed using paired Student's t test. Results are expressed as mean ± standard error of the mean, and p < 0.05 was considered to be statistically significant. Asterisks indicate statistically significant differences: *p < 0.05, **p < 0.01, and ***p < 0.001.

    Results
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

Characteristics of Current Expressed by Recombinant alpha 1C, alpha 2, and beta  Subunits of Ca2+ Channels in HEK-293 Cells. Expression of cloned Ca2+ channels in HEK-293 cells, using the above-mentioned protocol, produced IBa with biophysical and pharmacological similarities to the neuronal L-type Ca2+ channel expressed in its native environment. Representative IBa results elicited from these cells along with their current-voltage relationship are shown in Fig. 1, A and B. No significant inward current was observed until the depolarizing step reached -40 mV. Currents reached maximum amplitude at approximately 0 mV, and the reversal potential was approximately +50 mV. The peak current shows voltage dependence and inactivated only slowly.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Families of currents, current-voltage relationships, and voltage dependence of steady-state inactivation and activation of recombinant L-type Ca2+ channels expressed in HEK-293 cells. A, a representative family of current traces elicited by test pulses from a holding potential of -70 mV to test potentials ranging from -40 to +40 mV. Ba2+ (5 mM) was used as a charge carrier. B, current-voltage (I/V) relationship derived from the type of experiment illustrated in panel A. The peak currents are plotted as a function of the test pulse potentials (n = 7). The curve was fitted manually. C, voltage dependence of steady-state inactivation and activation. open circle , voltage dependence of steady-state inactivation determined from a holding potential of -70 mV by an 8-s prepulse from -100 mV to 0 mV in 10-mV increments preceding a test pulse from -70 to 0 mV. Normalized current amplitudes were plotted against prepulse potential. Curves were fitted using a Boltzmann function: I/Imax = [1 + exp{(V - V1/2)/K}]-1, with V1/2 = -53 mV and K = 13.3 mV. , voltage dependence of activation. Normalized current amplitude is plotted against the test potential (from data in panel B). Curves were fitted using a Boltzmann function: I/Imax = [1 + exp{-(V - V1/2)/K}]-1, with V1/2 = -18.8 mV and K = 4.7 mV. Cells were depolarized at a stimulation frequency of 0.1 Hz. Current responses were filtered at 2 kHz and leak current was subtracted.

Figure 1C depicts the voltage dependence of activation, or steady-state activation (minfinity ), of these Ca2+ channels, where minfinity was determined from the relative amplitudes of currents (I/Imax) elicited at different test membrane potentials. The voltage for half-maximal activation (V1/2) was -18.8 mV. The isochronal inactivation (hinfinity ) was determined using an 8-s inactivating prepulse. The inactivation curve is shown with slope factor (K) of 13.3 mV and V1/2 of -53.0 mV.

Figure 2 demonstrates DHP antagonist and agonist sensitivity of IBa elicited from these recombinant Ca2+ channels. Application of the agonist Bay K8644 (10 µM) caused a 100% increase of peak current (Fig. 2, A and C), whereas addition of the DHP antagonist nimodipine (10 µM) reduced the current by more than 90% (Fig. 2, B and C).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of dihydropyridines on peak L-type IBa in transfected HEK-293 cells. A, increase of current amplitude by 10.0 µM Bay K8644. B, reduction of current amplitude by 1.0 and 10.0 µM nimodipine (Nim). C, amplitude of inward Ba2+ current recorded before and after a 2-min exposure to Bay K8644 and nimodipine (Nim). The asterisk (star ) indicates a significant change in current amplitude in the presence of dihydropyridines compared with paired control values (p < 0.001). Values shown are the mean ± S.E.M. of four to five different cells. Cells were depolarized from -70 mV to 0 mV at a stimulation frequency of 0.1 Hz. Current responses were filtered at 2 kHz and leak current was subtracted.

Characteristics of Reduction of IBa by MeHg. As shown in representative traces (Fig. 3A), and in composite data from a number of recordings (Fig. 3B), continuous superfusion with MeHg caused a time-dependent reduction of IBa in transfected cells. The degree of reduction of current appeared to be approximately the same for both peak and sustained components of current (Fig. 3A). Thus, inactivation did not appear to be affected by MeHg under these conditions. The time course of effect on IBa of different concentrations of MeHg (0.125-5.0 µM) is shown in Fig. 3B. MeHg was applied after at least 5 min of stabilization of the control current. In comparison with control cells, which underwent 10% rundown of current during 9 min of continuous recording, MeHg treatment caused an apparent concentration-dependent reduction in the magnitude of IBa after leak subtraction. Reduction of peak current was incomplete and reached a plateau at approximately 80% reduction with 5.0 µM MeHg. Preliminary experiments indicated that application of 10 µM MeHg caused no further decrease in current amplitude (results not shown). The reduction in current amplitude by MeHg appeared to follow two distinct phases: one that was initially rapid, and the other, gradual and progressive. Depending upon the concentration of MeHg used, the rapid phase was completed between 100 and 150 s after beginning treatment. Lower concentrations of MeHg (0.125-1.25 µM) caused a more gradual decline in current amplitude. Figure 4 depicts the inhibition of peak current by various concentrations of MeHg after a 2-min exposure.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of MeHg on L-type IBa in HEK-293 cells. A, representative current traces depict the effect of 5.0 µM MeHg at different lengths of exposure. Leak current was not subtracted. B, time course of reduction of peak current amplitude by different concentrations of MeHg [triangle , 0 µM (control); , 0.125 µM; diamond , 1.25 µM; open circle , 2.5 µM; black-diamond , 5.0 µM). Values shown are the mean of five to seven different cells. Cells were depolarized from -70 mV to 0 mV at a stimulation frequency of 0.1 Hz. Current responses were filtered at 2 kHz and leak current was subtracted.


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 4.   Amplitude of inward Ba2+ current recorded before and after a 2-min exposure to different concentrations of MeHg in HEK-293 cells transfected with alpha 1C subunit along with the alpha 2 and beta  subunits of human neuronal Ca2+ channels. Cells were depolarized from -70 mV to 0 mV at a stimulation frequency of 0.1 Hz. Current responses were filtered at 2 kHz and leak current was subtracted. The asterisk (star ) indicates a significant change in peak current amplitude in the presence of MeHg when compared with control values (p < 0.001). Values shown are the mean of five to seven different cells and were obtained from panel B of Fig. 3.

Reduction by MeHg of current through putative L-type Ca2+ channels in differentiated PC12 cells has been shown previously to be irreversible (Shafer and Atchison, 1991). Therefore, we tested whether this phenomenon was also seen in recombinant expressed channels of similar phenotype. A 4-min wash with MeHg-free solution after 5 min of exposure to 5 µM MeHg did not reverse the reduction of IBa current (Fig. 5).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Irreversible reduction of peak L-type IBa by MeHg in HEK-293 cells. Peak current through expressed channels was reduced by 5.0 µM MeHg during exposure for 5 min; washing with MeHg-free extracellular solution did not reverse the reduction in current amplitude induced by MeHg. Cells were depolarized from -70 mV to 0 mV at a stimulation frequency of 0.1 Hz. Current responses were filtered at 2 kHz and leak current was subtracted. Values are the mean of five cells. Representative standard error bars are indicated.

Effect of DHPs on Reduction of IBa by MeHg. Current carried through these recombinant Ca2+ channels expressed in HEK-293 cells was sensitive to DHP-type drugs. MeHg has been reported to decrease the affinity of binding for [3H]nitrendipine to cortical synaptosomes (Shafer et al., 1990). Thus, we sought to determine whether MeHg caused its inhibitory effect by acting at sites that might overlap with those used by DHP-type Ca2+ channel antagonists or agonists. Consequently, nimodipine or Bay K8644 was applied in the continued presence of MeHg. As seen in Fig. 6A, 10 µM nimodipine was able to elicit a further decline in the current remaining, even after a 5-min exposure to 5 µM MeHg. Furthermore, after a similar reduction by MeHg, 10 µM Bay K8644 was able to cause a slight increase in the residual current (Fig. 6B).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of dihydropyridines on reduction of peak L-type IBa by MeHg in HEK-293 cells. A, peak current was reduced by ~60% within 5 min by 5.0 µM MeHg; addition of 10 µM nimodipine further reduced the residual IBa left after the peak effect of MeHg. B, reduction of Ba2+ currents caused by 5.0 µM MeHg was partly restored by 10 µM Bay K8644. Cells were depolarized from -70 mV to 0 mV at a stimulation frequency of 0.1 Hz. Current responses were filtered at 2 kHz and leak current was subtracted. Values are the mean of five to seven cells. Representative standard error bars are indicated.

Voltage Dependence of IBa Reduction by MeHg. To determine whether reduction by MeHg of the heterologously expressed L-type Ca2+ channel-mediated current is voltage-dependent, we applied a ramp protocol to obtain the current-voltage relationships for IBa. Inactivation properties were studied by varying the holding potential for 8 s before applying a test pulse to 0 mV in the presence or absence of MeHg. Figure 7A shows the current-voltage relationships for IBa before and after addition of 5.0 µM MeHg at different times of exposure. MeHg decreased the peak current amplitude at all potentials that activated current, but did not alter either the threshold of activation of IBa or the reversal potential. There were slight changes in the potential at which the maximum current was elicited; for example, there appeared to be a slight shift in the hyperpolarizing direction at 3 min (Fig. 7A). However, there was no apparent consistent pattern evident in these changes. MeHg had no effect on the inactivation curve (Fig. 7B).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of MeHg on current-voltage relationships and steady-state inactivation of L-type IBa in HEK-293 cells. A, current-voltage relationships for IBa recorded before and after addition of 5 µM MeHg for different exposure times. Test pulses were delivered by a ramp protocol of 150 ms duration and 30-s intervals between ramps as shown at the top of panel A; test potentials ranged from -60 mV to +60 mV with a holding potential of -70 mV. B, MeHg has no effect on voltage dependence of steady-state inactivation. The peak currents during a 480-ms test pulse from -70 mV to 0 mV were plotted against voltage with an 8-s conditioning prepulse. The peak currents before (control, solid circles) and after a 3-min exposure to 5.0 µM MeHg (MeHg, open circles) were normalized by the largest current recorded after conditioning prepulses ranging from -100 mV to 0 mV. The fitted curves are plotted using a Boltzmann function, I/Imax = [1 + exp{(V - V1/2)/K}]-1, with control V1/2 = -54.3 mV, K = 12.9 mV, and a 3-min exposure to MeHg V1/2 = -56.9 mV, K = 13.4 mV. Values in panel B are the mean ± S.E.M. of seven cells.

Frequency Dependence of IBa Reduction by MeHg. Some chemicals block ion channels in a use-dependent manner (Hille, 1992). During this process, the inhibitory effect is enhanced because of repetitive opening of the channels by increasing the stimulation frequency. The premise is that these inhibitors act either at sites within the channel or intracellularly. Shafer and Atchison (1991) and Sirois and Atchison (2000) demonstrated that the effect of MeHg on Ca2+ channels is use-dependent in PC12 and cerebellar granule cells, respectively. We examined whether this type of reduction could also occur in recombinant Ca2+ channels by stimulating transfected cells at frequencies of 0.1, 0.2, and 0.4 Hz. No frequency-dependent enhancement of MeHg-induced reduction of current amplitude was observed. Instead, the effect of MeHg on peak currents was either unchanged or actually reduced at higher stimulation frequencies (0.2 and 0.4 Hz; Fig. 8A), depending upon the duration of exposure to MeHg. At a stimulation frequency of 0.1 Hz, 5 µM MeHg reduced peak current by 67 ± 7% and 83 ± 3% after a 4-min and a 9-min exposure, respectively. When the stimulation frequency was increased, initially, the rate of decline of current amplitude appeared identical to that at 0.1 Hz. At both 0.2 and 0.4 Hz, there was a transient reversal of block by MeHg that occurred at ~150 s. In each case this reversal lasted for about 75 s and caused an ~33% increase in current amplitude despite the continued presence of MeHg. However, by a little over 200 s, current amplitude again began to decline. Although the rates of decline were not measured mathematically, visual inspection suggested that the rate of decline after this transient reversal was approximately equivalent to that prior to the reversal. At 0.2 Hz, the reduction of peak current induced by 5 µM MeHg was decreased to 43 ± 6% (p < 0.05) and 69 ± 2% (p < 0.05) after 4-min and 9-min exposures, respectively. At a stimulation frequency of 0.4 Hz, 5 µM MeHg induced an even smaller reduction than it did at 0.1 Hz during 4 min of exposure (36 ± 1%, p < 0.05). After a 9-min exposure, the reduction of peak current at 0.4 Hz (82 ± 3%) was not significantly different from that at 0.1 Hz. A similar reduction in inhibition was observed with 1.25 µM MeHg. At a stimulation frequency of 0.1 Hz, peak current amplitude was reduced by 70 ± 6% after 9 min of exposure to MeHg. After the stimulation frequency was increased to 0.2 Hz, peak current amplitude was reduced by only 50 ± 3% (Fig. 8B).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of different rates of stimulation on MeHg-induced reduction of peak L-type IBa in HEK-293 cells. Panel A, effect of 5.0 µM MeHg at stimulation frequencies of 0.1, 0.2, and 0.4 Hz. B, effect of 1.25 µM MeHg at stimulation frequencies of 0.1 and 0.2 Hz. Cells were depolarized from -70 mV to 0 mV. Current responses were filtered at 2 kHz and leak current was subtracted. Values are the mean of five to six cells. Representative standard error bars are indicated.

Increasing [Ba2+]e Reduces the Effectiveness of Block of IBa by MeHg. If the mechanism by which a divalent cation acts involves direct occlusion of the channel within the pore itself, the effectiveness of reduction in current would depend on the concentration of charge carrier. Increasing [Ca2+]e counters the magnitude of reduction of 45Ca2+ influx in synaptosomes by MeHg (Atchison et al., 1986; Shafer and Atchison, 1989), and increasing the [Ba2+]e slightly reduces the negative effect of MeHg on IBa in PC12 cells (Shafer and Atchison, 1991). As such, we sought to determine whether this action was associated with recombinant L-type Ca2+ channels. Indeed, the degree to which 5.0 µM MeHg reduced the peak current through these channels was dependent on the concentration of Ba2+ used. With 5 mM Ba2+ in the extracellular solution, reduction of the peak current reached 65 ± 6% after 3 min of exposure to 5.0 µM MeHg. However, with 20 mM Ba2+ as charge carrier, the reduction of peak current only reached 40 ± 6% (p < 0.05; Fig. 9). This suggests that increasing [Ba2+]e hinders MeHg action, possibly due to close proximity of binding sites (steric overlap) or interference between the binding sites (steric hindrance) for MeHg and Ba2+.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 9.   Effect of 5 mM and 20 mM Ba2+ in extracellular solution on current reduction induced by 5.0 µM MeHg in HEK-293 cells expressing L-type human neuronal Ca2+ channels. A, the time course of current reduction produced by 5.0 µM MeHg with 5 mM and 20 mM Ba2+ as charge carrier. Values are the mean time courses of 7 to 11 cells. B, amplitude of IBa current recorded before and after a 3-min exposure to 5.0 µM MeHg. The asterisk (star ) indicates a significant change in peak current amplitude in the presence of MeHg when compared with control values (p < 0.001). The number sign (#) indicates a significant change in peak current amplitude when compared with 5 mM Ba2+ as a charge carrier in the presence of MeHg (p < 0.05). Cells were depolarized from -70 mV to 0 mV at a stimulation frequency of 0.1 Hz. Current responses were filtered at 2 kHz and leak current was subtracted. Values shown are the mean ± S.E.M. of 7 to 11 cells.

    Discussion
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References

The present study is the first to examine the inhibitory actions of MeHg on a single identified phenotype of voltage-sensitive Ca2+ channels. While corroborating several aspects of previous studies examining the effects of MeHg on Ca2+ channel function in native cells, our study extends them in several important ways. First, MeHg exerts a concentration-dependent depressant effect on function of neuronal L-type high voltage-activated Ca2+ channels that was not readily reversible by washing with MeHg-free solution. Second, unlike the situation seen for mixed populations of Ca2+ channels in their native environment, reduction of current carried through these recombinant L-type Ca2+ channels by MeHg is not total and apparently is not mediated by action at the DHP binding site. Third, concentration of charge carrier can modulate the inhibitory effects of MeHg, due possibly to steric hindrance or overlap. The overall shape of the current recordings as well as the voltage and time dependence of the current recorded from cells transfected with recombinant Ca2+ channels comprising alpha 1C-1, alpha 2b, and beta 3a Ca2+ channel subunits resemble those of native L-type Ca2+ channels. Furthermore, the IBa from these recombinant Ca2+ channels exhibits the pharmacological sensitivities to DHPs in the manner and concentration range reported in numerous studies on native DHP-sensitive L-type Ca2+ channels.

MeHg disrupts normal Ca2+ channel function in a variety of preparations as seen using synaptosome 45Ca2+ influx, ligand binding, and electrophysiological techniques (Shafer and Atchison, 1989; Shafer et al., 1990; Hewett and Atchison, 1992; Leonhardt et al., 1996; Shafer, 1998). Sirois and Atchison (2000) demonstrated that MeHg affects multiple subtypes of Ca2+ channels including L-type in rat cerebellar granule cells. However, there are no previous studies on the discrete effects of MeHg on identified subtypes of Ca2+ channels in isolation, mainly because of the multiplicity of Ca2+ channel types that coexist in most primary cultures of neurons, such as cerebellar granule cells, and the lack of completely specific pharmacological probes. Our results show that low concentrations of MeHg (0.125-5.0 µM) rapidly reduced peak IBa in a time- and concentration-dependent manner through recombinant, heterologously expressed L-type Ca2+ channels, a phenotype expressed in several kinds of neuronal as well as non-neuronal cells. Currents through recombinant L-type channels were affected at lower concentrations of MeHg than were ostensibly similar native L-type currents in rat PC12 cells (Shafer and Atchison, 1991; Shafer, 1998) and dorsal root ganglion cells (Leonhardt et al., 1996), but the lower concentration of charge carrier used in our present study as compared with other studies may have contributed to this effect. Current from recombinant channels was similar in sensitivity to MeHg to native currents in rat cerebellar granule cells (Sirois and Atchison, 2000) using the same [Ba2+]e.

Other subtle differences are also apparent between our results and those from native channels. For example, in differentiated PC12 cells, MeHg (10-20 µM) rapidly and completely blocked whole-cell current through presumed L-type Ca2+ channels (Shafer and Atchison, 1991). In contrast, the recombinant L-type Ca2+ channel current expressed in HEK-293 cells could be blocked only incompletely by MeHg. This difference in pharmacological sensitivity between native and cloned, heterologously expressed channels has also been reported for calcicludine reduction of L-type (Stotz et al., 2000), omega -agatoxin IVA reduction of P/Q-type (Bourinet et al., 1999), and peptide spider toxin DW13.3 reduction of N-type (Sutton et al., 1998) currents. One possible reason for this apparent difference in our experiments could be the use of a beta  subunit with properties different from the native beta  subunits that associate with the corresponding native L-type Ca2+ channels; beta  subunits are known to modulate channel kinetics (Hofmann et al., 1999). Different beta  subunit isoforms cause shifts in the kinetics and voltage dependence of gating and thus result in substantially altered alpha 1 subunit function. In the Xenopus laevis oocyte transfection system, inactivation and recovery from inactivation of "L-type" channels depend not only on the nature of the beta  subunit, but also on the splice-variant of L-type channel expressed (Soldatov et al., 1997).

In nerve growth factor-differentiated PC12 cells, which express L-type Ca2+ channels (Plummer et al., 1989; Usowicz et al., 1990), MeHg appears to reduce current amplitude in a voltage-dependent manner (Shafer and Atchison, 1991). In synaptosomes, reduction of 45Ca2+ influx induced by MeHg also appears to be voltage-dependent (Shafer et al., 1990). However, in rat cerebellar granule cells, which possess multiple types of Ca2+ channels (L, N, P/Q, and R) (Randall and Tsien, 1995), reduction of Ca2+ current amplitudes by 0.25 to 1.0 µM MeHg was not voltage-dependent (Sirois and Atchison, 2000). In the experiments presented here, the reduction of peak current by 5.0 µM MeHg occurs at all membrane potentials and does not alter either the threshold of activation of IBa or the reversal potential. MeHg did cause some slight changes in the potential at which maximum current is elicited. However, these effects were not consistent, nor was the steady-state inactivation curve altered.

If reduction of current amplitude by MeHg occurs through binding within the pore of the channels or intracellularly, it should exhibit "use-dependence". In PC12 cells the effect of 5.0 µM MeHg was facilitated by increasing stimulation frequency from 0.1 to 0.2 or 0.4 Hz (Shafer and Atchison, 1991). In primary cultures of cerebellar granule cells, increasing the stimulation rate hastened the onset and increased the magnitude of reduction at both 0.25 and 0.5 µM MeHg, but not at 1 µM (Sirois and Atchison, 2000). In contrast, in our experiments increasing stimulation does not facilitate the effect of 5.0 µM MeHg and, in fact, decreases it to some extent. It is difficult to explain definitively the reason for the brief reversal of MeHg effect (Fig. 8A) at the higher rates of stimulation. We have also seen a similar phenomenon of temporary reversal under certain conditions of blocking action of MeHg on Ca2+-dependent synaptic transmission in isolated brain slices (Yuan and Atchison, 1993) and motor end plates (Traxinger and Atchison, 1987). Perhaps a subset of Ca2+ channels remains closed during the lower stimulation rate but opens up during the faster stimulations, causing current flow for a limited time before the effect of MeHg sets in. As such, there may be a frequency- and time-dependent "revealing" of additional channels that become available to conduct current before they too are affected by the MeHg.

Increasing the extracellular concentration of Ba2+ from 5 mM to 20 mM partially attenuated the reduction of current by MeHg. This observation is consistent with effects on whole cell Ca2+ currents previously reported in PC12 cells (Shafer et al., 1990), effects on synaptosomal 45Ca2+ influx (Shafer and Atchison, 1989), and effects at the neuromuscular junction (Traxinger and Atchison, 1987). It suggests that MeHg may compete with Ba2+ for the same active sites within the channel (steric overlap) or there may be a steric hindrance due to close proximity of their binding sites.

The original aim of this study was to begin to reconcile differences in action of MeHg between results of acute electrophysiological-type studies with those of functional studies in which antagonists of L-type Ca2+ channels delay or protect against MeHg-induced neurotoxicity. One possibility was that L-type channels were not blocked by MeHg and perhaps even had current flow enhanced by the metal. However, MeHg reduces amplitude of currents carried through recombinant L-type channels, albeit not completely. A second possibility was that short-term exposures to MeHg impeded Ca2+ channel function, whereas longer exposures might facilitate current flow. The present study did not address this possibility directly; however, Shafer et al. (2002) find that exposure of PC12 cells to micromolar concentrations of MeHg for up to 24 h still impeded current flow. The most parsimonious explanation for this dichotomy is that MeHg itself enters cells through Ca2+ channels of various phenotypes--- including L-type. Such a phenomenon is reported to occur for other neurotoxic metals such as Pb2+ (Simons and Pocock, 1987) and Cd2+ (Hinkle et al., 1987, 1992; Hinkle and Osborne, 1994) and is consistent with results from in situ preparations in which KCl- or veratridine-induced depolarizations hastened the onset of increased miniature end-plate potential frequency with MeHg, even in the absence of extracellular Ca2+ (Atchison, 1986, 1987). Thus, the ability of L-type Ca2+ channel blockers to protect against actions of MeHg may then reflect their ability to prevent its entry into the cell prior to producing intracellular actions. The question, then, is, how does MeHg enter the channel if the blocking action was neither voltage-dependent nor use-dependent? Both of these factors should enhance entry of MeHg into the channel.

In conclusion, MeHg alters function of heterologously expressed, recombinant human neuronal L-type Ca2+ channels at low micromolar concentrations, concentrations well within the range associated with MeHg neurotoxicity in vivo. The mechanism by which this occurs and the consequences of this action are not yet clear. However, this action is temporally among the earliest reported for MeHg and, thus, would be expected to contribute ultimately to the neurotoxic effects.

    Acknowledgments

We thank SIBIA Neurosciences, now Merck Research Laboratories, for the generous contribution of the Ca2+ channel cDNA clones. We also thank Dr. Peter J. R. Cobbett for discussion and constructive criticisms throughout the work presented here.

    Footnotes

Accepted for publication April 11, 2002.

Received for publication January 4, 2002.

Supported by National Institute of Environmental Health Sciences Grant ES03299. Preliminary results of this article were presented at the 30th Annual Meeting of the Society for Neuroscience in New Orleans, LA, and published in abstract form in Soc Neurosci Abstr 26:621, 2000.

DOI: 10.1124/jpet.102.032748

Address correspondence to: Dr. Bill Atchison, Department of Pharmacology and Toxicology, Michigan State University, B-331 Life Sciences Building, East Lansing, MI 48824-1317. E-mail: atchiso1{at}msu.edu

    Abbreviations

MeHg, methylmercury; HEK, human embryonic kidney; DHP, dihydropyridine; Bay K8644, S-(-)-1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-[trifluoromethyl]phenyl)-3 pyridine carboxylic acid methyl ester; GFP, green fluorescent protein; IBa, Ba2+ current; PC12, pheochromocytoma; [Ba2+]e, extracellular barium concentration.

    References
Top
Abstract
Introduction
Experimental Procedures
Results
Discussion
References


0022-3565/02/3022-0424-0432$07.00
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C. J. Herden, N. E. Pardo, R. K. Hajela, Y. Yuan, and W. D. Atchison
Differential Effects of Methylmercury on {gamma}-Aminobutyric Acid Type A Receptor Currents in Rat Cerebellar Granule and Cerebral Cortical Neurons in Culture
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 517 - 528.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Tarabova, M. Kurejova, Z. Sulova, M. Drabova, and L. Lacinova
Inorganic Mercury and Methylmercury Inhibit the Cav3.1 Channel Expressed in Human Embryonic Kidney 293 Cells by Different Mechanisms
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 418 - 427.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. K. Hajela, S.-Q. Peng, and W. D. Atchison
Comparative Effects of Methylmercury and Hg2+ on Human Neuronal N- and R-Type High-Voltage Activated Calcium Channels Transiently Expressed in Human Embryonic Kidney 293 Cells
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1129 - 1136.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y. Yuan and W. D Atchison
Methylmercury differentially affects GABAA receptor-mediated spontaneous IPSCs in Purkinje and granule cells of rat cerebellar slices
J. Physiol., July 1, 2003; 550(1): 191 - 204.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Peng, R. K. Hajela, and W. D. Atchison
Characteristics of Block by Pb2+ of Function of Human Neuronal L-, N-, and R-Type Ca2+ Channels Transiently Expressed in Human Embryonic Kidney 293 Cells
Mol. Pharmacol., December 1, 2002; 62(6): 1418 - 1430.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peng, S.
Right arrow Articles by Atchison, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peng, S.
Right arrow Articles by Atchison, W. D.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition